APLM Apollomics Inc.

Nasdaq N/A


$ 14.61 $ -0.41 (-2.79 %)    

Friday, 21-Nov-2025 15:36:27 EST
QQQ $ 592.89 $ 5.56 (0.95 %)
DIA $ 463.26 $ 3.78 (0.82 %)
SPY $ 660.76 $ 5.75 (0.88 %)
TLT $ 89.46 $ -0.19 (-0.21 %)
GLD $ 373.50 $ -0.49 (-0.13 %)
$ 14.75
$ 14.67
$ 14.13 x 20
$ 14.65 x 10
$ 14.26 - $ 15.11
$ 3.66 - $ 42.12
30,018
na
16.27M
$ 0.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 apollomics-enters-into-settlement-agreement-with-twvc-goldlink-partners-investment-and-twvc-panglin-group-investment-to-pay-5m-in-cash-and-87975778-in-associated-legal-expenses

-SEC Filing

 apollomics-receives-39m-payment-from-launxp-maintains-active-collaboration-on-vebreltinib-development

Pursuant to the Company's Form 6-K filed on July 25, 2025 (the "July 2025 6-K"), Apollomics Inc. ("Apollomics&#...

 nasdaq-cancels-delisting-hearing-for-apollomics-confirms-compliance-with-continued-listing-standards

Apollomics Inc. (NASDAQ:APLM) ("Apollomics" or the "Company"), a California based late-stage clinical biopharma...

Core News & Articles

The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in Apollomics Inc. Class A ordinary shares (NASDAQ:AP...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION